Expert Opinion on Biological Therapy 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Bispecific antibodies as monotherapy or in combinations for hematological malignancies: latest updates from the EHA 2023 annual meeting
Volume 23, Issue 12, July - December 2023, Page 1193-1195 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 28, 2023 Category: Drugs & Pharmacology Authors: Xingchen LiPeng ZhangHao SunLijie HanZhongxing JiangJifeng Yua Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Chinab Department of Orthopedics, Affiliated Hospital of Changchun University of Traditional Chines Source Type: research
An evaluation of rozanolixizumab-noli for the treatment of anti-AChR and anti-MuSK antibody-positive generalized myasthenia gravis
Volume 23, Issue 12, July - December 2023, Page 1163-1171 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 28, 2023 Category: Drugs & Pharmacology Authors: Alexandria MaticNouf AlfaidiVera BrilThe Ellen & Martin Prosserman Centre for Neuromuscular Diseases, University Health Network, University of Toronto, Toronto, Ontario, Canada Source Type: research
Adjuvant immunotherapy for locally advanced renal cell carcinoma
Volume 23, Issue 12, July - December 2023, Page 1265-1275 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 28, 2023 Category: Drugs & Pharmacology Authors: Michail AlevizakosDavid McDermotta Department of Hematology/Medical Oncology, Riverside Cancer Specialists of Tidewater, Chesapeake, VA, USAb Hematology/Oncology Division, Beth Israel Deaconess Medical Center, Boston, MA, USA Source Type: research
Integrating CAR-T cell therapy into the management of DLBCL: what we are learning
Volume 23, Issue 12, July - December 2023, Page 1277-1285 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 28, 2023 Category: Drugs & Pharmacology Authors: Massimo MartinoFilippo Antonio CanaleGaetana PortoChiara VerduciGiovanna UtanoGiorgia PolicastroJessyca German òCaterina AlatiLudovica SantoroLucrezia ImbalzanoMartina Piteaa Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Department of Hem Source Type: research
Biological therapy in polymyalgia rheumatica
Volume 23, Issue 12, July - December 2023, Page 1255-1263 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 28, 2023 Category: Drugs & Pharmacology Authors: Daniel Wendlinga Rheumatology, CHU (University Teaching Hospital), Besan çon, Franceb EA4266 EPILAB, Université de Franche-Comté, Besançon, France Source Type: research
Etranacogene dezaparvovec-drlb gene therapy for patients with hemophilia B (congenital factor IX deficiency)
Volume 23, Issue 12, July - December 2023, Page 1173-1184 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 28, 2023 Category: Drugs & Pharmacology Authors: Tro SekayanDana H. SimmonsAnnette von Drygalskia Division of Hematology/Oncology, Department of Medicine, University of California, San Diego, San Diego, CA, USAb Capitol Scientific, Washington DC, USA Source Type: research
Biological therapies for the treatment of psoriasis in pediatrics
Volume 23, Issue 12, July - December 2023, Page 1219-1226 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 28, 2023 Category: Drugs & Pharmacology Authors: Mariam NikolaishviliVito Di Lerniaa Faculty of Medicine, Ivane Javakhishvili, Tbilisi State University, Tbilisi, Georgiab Dermatology Unit, Arcispedale Santa Maria Nuova, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy Source Type: research
Antibody based therapeutics for autoimmune hemolytic anemia
Volume 23, Issue 12, July - December 2023, Page 1227-1237 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 28, 2023 Category: Drugs & Pharmacology Authors: Francesca CavallaroWilma BarcelliniBruno Fattizzoa Hematology Unit, Fondazione IRCCS Ca ’ Granda Ospedale Maggiore Policlinico, Milan, Italyb Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy Source Type: research
Bulevirtide and emerging drugs for the treatment of hepatitis D
Volume 23, Issue 12, July - December 2023, Page 1245-1253 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 28, 2023 Category: Drugs & Pharmacology Authors: Helen Y XuJamie O YangPhillip H ChenSteven-Huy B Hana Department of Medicine, UCLA Health, Los Angeles, CA, USAb Clinical Fellow in Gastroenterology, Department of Gastroenterology, UCLA Health, Los Angeles, CA, USAc Pfleger Liver Institute, UCLA Health, Source Type: research
Anacaulase-bcdb for the treatment of severe thermal burns
Volume 23, Issue 12, July - December 2023, Page 1185-1191 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 28, 2023 Category: Drugs & Pharmacology Authors: Yaron ShohamYuval KriegerJeremy Govermana Plastic and Reconstructive Surgery Department and Burn Unit, Soroka University Medical Center, Beer Sheba, Israelb Plastic Surgery Department and Burn Unit, Ben-Gurion University of the Negev Faculty of Health Sci Source Type: research
An up-to-date review of approved and emerging antibody therapies for idiopathic pulmonary fibrosis
Volume 23, Issue 12, July - December 2023, Page 1239-1244 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 28, 2023 Category: Drugs & Pharmacology Authors: Jacopo SimonettiGiacomo SgallaLuca Richeldia Unita Operativa Complessa di Pneumologia, Dipartimento di Neuroscienze, Organi di Senso e Torace, Universit à Cattolica del Sacro Cuore, Rome, Italyb Unita Operativa Complessa di Pneumologia, Dipartimento di N Source Type: research
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study
Volume 23, Issue 12, July - December 2023, Page 1307-1315 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 28, 2023 Category: Drugs & Pharmacology Authors: A ChiricozziSM FerrucciL Di NardoN GoriA BalatoM OrtoncelliM MaurelliM GalluzzoM Munera CamposT SeremetG CaldarolaC De SimoneE IppolitiT TorresS GkalpakiotisC ConradJM CarrascosaL BianchiG ArgenzianoS RiberoG GirolomoniAV MarzanoK Perisa Dermatologia, Dip Source Type: research
Pharmacokinetic and pharmacodynamic similarity of biosimilar natalizumab (PB006) to its reference medicine: a randomized controlled trial
Volume 23, Issue 12, July - December 2023, Page 1287-1297 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 28, 2023 Category: Drugs & Pharmacology Authors: Hendrik WesselsOliver von RichterMaria VelinovaJosef H öflerPaul ChamberlainArno KrommingaDirk LehnickKarsten Rotha Polpharma Biologics S.A, Gdansk, Polandb Hexal AG (A Sandoz company), Holzkirchen, Germanyc Early Development Services, ICON, Groningen, T Source Type: research
Use of real-world data to assess the effectiveness of ustekinumab in treating IBD patients: a retrospective linked database study in northwest London
Volume 23, Issue 12, July - December 2023, Page 1317-1329 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 28, 2023 Category: Drugs & Pharmacology Authors: Nik KamperidisMoulesh ShahSophie YoungEvgeniy GalimovShruti SweeneyNaila Arebia Department of Gastroenterology, St Marks Hospital, London, UKb Imperial College Health Partners, London, UKc Janssen Cilag Limited, High Wycombe, UK Source Type: research
The safety of canakinumab in systemic juvenile idiopathic arthritis and autoinflammatory diseases in pediatric patients: a multicenter study
Volume 23, Issue 12, July - December 2023, Page 1299-1306 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 28, 2023 Category: Drugs & Pharmacology Authors: Taner Co şkunerŞengül ÇağlayanÖzlem AkgünRüya TorunEmine Nur Sunar Yaylaİ̇lknur BagrulGülşah KılbaşGülçin Otar YenerHülya KöseKübra ÖztürkÖzge BabaMustafa ÇakanFerhat DemirHafize Emine SönmezMukaddes KalyoncuSara Sebnem KılıçSel Source Type: research
